Evidence map›Paper›PMID 15583328›Full record

ArticleJournal of clinical microbiology2004

Identification and discrimination of Burkholderia pseudomallei, B. mallei, and B. thailandensis by real-time PCR targeting type III secretion system genes.

F M Thibault, E Valade, D R Vidal

Open access · greenAbstract readEvaluation Study
In one paragraph

Article in Journal of clinical microbiology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
5.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 109 citations in OpenAlex.

  1. Article
  2. Article
  3. Identification ofMicrobiology spectrum · 2024
    Article
  4. Article
  5. Detection ofFrontiers in public health · 2023
    Article
  6. Sequence-based detection and typing procedures forFrontiers in veterinary science · 2022
    Review
  7. Article
  8. Preliminary Evaluation of Rapid Visual Identification ofFrontiers in cellular and infection microbiology · 2021
    Article
  9. Human Melioidosis.Clinical microbiology reviews · 2020
    Review
  10. Article
  11. First record of Burkholderia mallei Turkey 10 strain originating from glanderous horses from Brazil.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2019
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Laboratory diagnosis of melioidosis: past, present and future.Experimental biology and medicine (Maywood, N.J.) · 2015
    Review
  18. Melioidosis diagnostic workshop, 2013.Emerging infectious diseases · 2015
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

F M ThibaultCentre de Recherches du Service de Santé des Armées, 24 Avenue des maquis du Grésivaudan, B.P. 87, F-38702 La Tronche, France. fthibault@crssa.net
E Valade
D R Vidal
Service de Santé des Armées · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Burkholderia pseudomallei and B. mallei are two highly pathogenic bacteria, responsible for melioidosis and glanders, respectively. The two are closely related and can also be mistaken for B. thailandensis, a nonpathogenic species. To improve their differential identification, we describe a hydrolysis probe-based real-time PCR method using the uneven distribution of type III secretion system genes among these three species.

Indexed as

Bacterial Typing TechniquesPolymerase Chain ReactionAnimalsBacterial ProteinsBurkholderiaBurkholderia malleiBurkholderia pseudomalleiDNA ProbesGlandersHorse DiseasesHorsesHumansHydrolysisMelioidosisSpecies SpecificityBacterial ProteinsDNA Probes

Identifiers

PMID15583328
PMCPMC535269
OpenAlexW2116832454

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.